Innovation and Innovation Partnership

Rydvalová, Petra; Skala, Marek

doi:10.1007/978-3-030-79907-6_4

Cited by 5 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Production innovation (proinno) and business process innovation (bprocinn). Product innovation is where a firm has introduced to the market a new or improved good or service that differs significantly from the firm's previous goods or services while business process innovation is a new or improved business proccess introduced on the market by firms that differ significantly from the previous business processes by the firm (Rydvalova & Skala, 2021).…”

Section: Description Of Variablesmentioning

confidence: 99%

Knowledge Management: The Value of Inter and Intra-firm Activities Towards Innovation Performance

Arthur,

Stejskal

2023

ECKM

View full text Add to dashboard Cite

Firms mainly depend on innovation to remain competitive in business. New knowledge is a major resource for firms on the path of achieving innovation performance. This paper seeks to examine how intra-firm and inter-firm activities promote knowledge sharing toward innovation performance. We used the variables channels of information to represent inter-firm activities and workplace organization methods to represent intra-firm knowledge-sharing activities. The proxies for innovation performance were product innovation and business process innovation. Cross-sectional country-level data from CIS 2018 for 17 countries within the EU region was used for our study. The OLS regression method was used for the analysis. While existing studies concentrate on inter-firm knowledge transfer and single country-level studies, our study focuses on a blend of intra-firm and intra-firm cross-country studies. We also emphasized the value of knowledge sharing and cognition in the knowledge transfer process toward achieving firm innovation performance. Our model was built on the knowledge-based view (KBV) and social network theory (SNT). We found that cross-functional workgroups, conferences, trade fairs and exhibitions have a positive significant impact on both product and business process innovation. Published patent had a significant impact on product innovation but was not statistically significant for business process innovation. In conclusion, we found that intra-firm knowledge-sharing activities impact more on innovation performance of firms more than inter-firm knowledge-sharing activities of firms in the EU. Our study is limited to using cross-sectional data and the number of countries within the EU involved in the study. We believe longitudinal data and the involvement of more EU countries in future studies will yield robust findings for more reliable inferences.

show abstract

Section: Description Of Variablesmentioning

confidence: 99%

Knowledge Management: The Value of Inter and Intra-firm Activities Towards Innovation Performance

Arthur,

Stejskal

2023

ECKM

View full text Add to dashboard Cite

show abstract

“…First, the allocation of pharmaceutical resource elements should be optimized. According to Schumpeter, innovation is the introduction of never-before-seen combinations of production factors and production conditions into the production system, the upgrading of production factor resources or the optimal combination of production factors, the integration of innovation resources in the region, the formation of regional innovation synergy, and the improvement of production and output efficiency of industrial clusters, thus promoting the innovative development of industrial clusters [ 34 , 35 ]. The Shijiazhuang pharmaceutical excipients and preparations industrial cluster concentrates more than 95% of the pharmaceutical science and technology innovation elements in Hebei Province.…”

Section: Mechanism Of Pharmaceutical Industrial Cluster Innovation Ev...mentioning

confidence: 99%

Evolutionary Path and Innovative Development of Pharmaceutical Industrial Cluster—A Case Study of Shijiazhuang, China

Shan

2022

IJERPH

View full text Add to dashboard Cite

The innovation and development practices of the pharmaceutical industry are of great importance for the continual enhancement of public health. Industrial clusters are one of the important means by which the pharmaceutical industry can be transformed and developed, but there is a lack of research on the evolutionary path and development innovation of pharmaceutical industrial clusters. As a country with a major pharmaceutical industry, the transformation and development path of traditional pharmaceutical industrial clusters in China has important reference value for the sustainable development of the global pharmaceutical industry. Through an analysis of the evolution of traditional pharmaceutical industrial clusters in Shijiazhuang, this study explores the law of the dynamic evolution of pharmaceutical industrial clusters and the associated mechanisms. Specifically, we conclude that the evolutionary path of traditional pharmaceutical industrial clusters can be divided into the government-led pharmaceutical industrial cluster start-up stage, the government-guided pharmaceutical industrial cluster development stage, and the government-served pharmaceutical industrial cluster transformation stage. The operating mechanisms include a self-organization mechanism, an innovation-driven mechanism, and an outward associated mechanism, each of which plays different roles in the different stages of the dynamic evolution of the cluster, and the synergistic operation of the three mechanisms forms an important basis for the evolution of pharmaceutical industrial clusters. We found that the innovation development of traditional pharmaceutical industrial clusters is influenced by the synergy of the self-organization, innovation-driven, and outward associated mechanisms. The self-organization mechanism is a necessary condition for pharmaceutical industrial clusters to realize the transition from disorder to order. The innovation-driven mechanism is the core driving force for the innovative development of pharmaceutical industrial clusters. Finally, the outward associated mechanism is the main means by which pharmaceutical industrial clusters integrate into the global value chain.

show abstract